MENU
AURX
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Nuo Therapeutics (AURX) Ownership - Who owns Nuo Therapeutics?
Profile
Industry
N/A
Address
8285 El Rio
Phone
+1 346 396-4770
Employees
10
Web
https://www.nuot.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
69.9M
P/E Ratio
N/A
Total Cash
683.84K
Projected Growth
N/A
Total Debt
179.31K
Revenue
1.17M
Risk (Beta)
-815.86
Dividend Yield
N/A
Total Cash/Share
0.01
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
AURX
Capitalization
69.9M
P/E Ratio
N/A
Risk (Beta)
-815.86
Dividend Yield
N/A
Total Cash
684K
Total Cash/Share
0.01
Total Debt
179K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
1.17M
ROE
N/A
Book Value
890K
P/B Ratio
78.74
Cash Flow
N/A
Earnings
-0.06
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4.66K
Current Ratio
1.88
Current Revenue Per Employee
41216.78
Dividends Per Share - Security
N/A
EBITDA
-2.39M
Float
N/A
Float - Current
N/A
Gross Income Margin
72.91
Revenue To Assets
-149.45
Shares Held By Institutions
2.74K
Shares Outstanding - Current
46.6M
Total Liabilities
829K
Total Volume MTD
N/A
Value
-1
Gain YTD
7.143
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
8285 El Rio
Phone
+1 346 396-4770
Employees
10
Web
https://www.nuot.com